MS clinical trial design for the future

The Clinical Outcomes Task Force has been challenged to develop new easily administered composite outcomes that are more sensitive, highly reliable, properly validated, and measure more effectively the broad spectrum of independent dimensions of MS. The Task Force on Use of MRI in MS Clinical Trials...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Multiple sclerosis 1996-07, Vol.1 (6), p.393-399
1. Verfasser:	Goodkin, Donald E
Format:	Artikel
Sprache:	eng
Schlagworte:	Clinical Trials, Phase I as Topic Clinical Trials, Phase II as Topic Epidemiologic Research Design Forecasting Humans Magnetic Resonance Imaging Multiple Sclerosis - therapy Recurrence Remission Induction Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!